Ni Lian

441 citations
22 papers · 281 indexed · h-index 10
Topics
Inflammasome and immune disorders (9 papers)Psoriasis: Treatment and Pathogenesis (5 papers)Dermatology and Skin Diseases (4 papers)
Journals
SHILAP Revista de lepidopterologíaCell Death and DiseaseBMJ Open

In The Last Decade

Ni Lian

21 papers receiving 275 citations

Peers

Ni Lian
Comparison fields: 5 of 68
  • Immunology 124
  • Molecular Biology 110
  • Dermatology 87
  • Pulmonary and Respiratory Medicine 33
  • Epidemiology 33
Replace Daniel Brănişteanu with:
Daniel Brănişteanu Romania
Katharina Haas Germany
Michael M. Cho United States
Sérgio C. L. Almeida Brazil
Kirsi Isoherranen Finland
Michael A. Podolsky United States
Zia U.A. Mollah Japan
Liteng Yang China
Ni Lian relative to Daniel Brănişteanu Romania Daniel Brănişteanu's profile →
Citations per field
00.5×8.3×
Daniel Brănişteanu · 1×
Citations per year

Countries citing papers authored by Ni Lian

Since Specialization
Citations

This map shows the geographic impact of Ni Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Lian more than expected).

Fields of papers citing papers by Ni Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Lian. The network helps show where Ni Lian may publish in the future.

Co-authorship network of co-authors of Ni Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Lian. A scholar is included among the top collaborators of Ni Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Lian. Ni Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 1
4 3
5 10
6 30
7 8
8 35
9 27
10 19
11 11
12 9
13 2
14 13
15 14
16 7
17 56
18 6
19
[The application of the physical factors for the rehabilitation of the children presenting with bronchial asthma].
1
20
Insomnia treated by auricular pressing therapy.
12

About Ni Lian

Ni Lian is a scholar working on Dermatology, Immunology and Hematology, having authored 22 papers that have together received 281 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (9 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Dermatology and Skin Diseases (4 papers). The work is most often cited by research in Dermatology (87 citations), Immunology (124 citations) and Nephrology (15 citations). Ni Lian has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Min Li, Min Chen, Xu Chen, Yujie Chen, Heng Gu, Lihao Liu, Yun Zhu, Yu Hu, Andrzej Bartke and Rong Yuan. Their work appears in journals such as SHILAP Revista de lepidopterología, Cell Death and Disease and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026